Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Ipragliflozin | 761423-87-4 | 99.7% | 404.45 | 100 MG
Supplier: Medchemexpress LLC HY14894100MG
Ipragliflozin is an orally active and selective SGLT2 inhibitor that functions as an antidiabetic agent. It has been shown to exhibit potent inhibitory activity against human, rat, and mouse SGLT2, and is intended for research purposes only.
- Selective SGLT2 inhibitor
- Demonstrates antihyperglycemic effects
- Suppresses the growth of MCF-7 human breast cancer cell lines in vitro
- Inhibits DNA synthesis in MCF-7 cells in vitro
- Reduces HbA1c and blood glucose levels in vivo
- Increases pancreatic insulin content in vivo
- Increases urinary glucose excretion in vivo
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?